• Explore /
  • Poster
  • / Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC.

Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC.

Abstract Poster

Authors

null

Jiyun Lee

Lung Cancer Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea

Jiyun Lee , Jaeho Cho , Chang Lee , Chang Young Lee , Jin Gu Lee , Dae Joon Kim , Hyo Sup Shim , Sun Min Lim , Hye Ryun Kim , Byoung Chul Cho , Min Hee Hong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03694236

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 8556)

DOI

10.1200/JCO.2023.41.16_suppl.8556

Abstract #

8556

Poster Bd #

183

Abstract Disclosures

Similar Posters

First Author: Yufei Liu

First Author: Samuel Rosner

First Author: Benjamin J. Solomon

First Author: Boris Sepesi